Resmed Inc Stock Number Of Employees
| RMD Stock | USD 219.70 1.41 0.64% |
ResMed Inc fundamentals help investors to digest information that contributes to ResMed's financial success or failures. It also enables traders to predict the movement of ResMed Stock. The fundamental analysis module provides a way to measure ResMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ResMed stock.
ResMed | Number Of Employees |
ResMed Inc Company Number Of Employees Analysis
ResMed's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
ResMed Number Of Employees Driver Correlations
Understanding the fundamental principles of building solid financial models for ResMed is extremely important. It helps to project a fair market value of ResMed Stock properly, considering its historical fundamentals such as Number Of Employees. Since ResMed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ResMed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ResMed's interrelated accounts and indicators.
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, ResMed Inc is currently employing 0.0 people. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The number of employees for all United States stocks is 100.0% higher than that of the company.
ResMed Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ResMed's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics of similar companies.ResMed is currently under evaluation in number of employees category among its peers.
ResMed ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ResMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ResMed's managers, analysts, and investors.Environmental | Governance | Social |
ResMed Fundamentals
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.25 % | ||||
| Operating Margin | 0.33 % | ||||
| Current Valuation | 32.58 B | ||||
| Shares Outstanding | 146.87 M | ||||
| Shares Owned By Insiders | 0.70 % | ||||
| Shares Owned By Institutions | 62.85 % | ||||
| Number Of Shares Shorted | 8.73 M | ||||
| Price To Earning | 73.48 X | ||||
| Price To Book | 6.14 X | ||||
| Price To Sales | 6.55 X | ||||
| Revenue | 4.69 B | ||||
| Gross Profit | 2.91 B | ||||
| EBITDA | 1.53 B | ||||
| Net Income | 1.02 B | ||||
| Cash And Equivalents | 273.71 M | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 873.93 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 2.80 X | ||||
| Book Value Per Share | 35.77 X | ||||
| Cash Flow From Operations | 1.4 B | ||||
| Short Ratio | 8.12 X | ||||
| Earnings Per Share | 8.48 X | ||||
| Price To Earnings To Growth | 1.43 X | ||||
| Target Price | 270.09 | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 32.27 B | ||||
| Total Asset | 6.87 B | ||||
| Retained Earnings | 4.99 B | ||||
| Working Capital | 1.45 B | ||||
| Current Asset | 1.42 B | ||||
| Current Liabilities | 637.99 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.02 % | ||||
| Net Asset | 6.87 B | ||||
| Last Dividend Paid | 2.02 |
About ResMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out ResMed Piotroski F Score and ResMed Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.649 | Dividend Share 2.02 | Earnings Share 8.48 | Revenue Per Share | Quarterly Revenue Growth 0.103 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.